Nationwide Amazon Pharmacy Delivery Expansion Sparks Double-Digit Drop in Hims Shares
Amazon Pharmacy expanded its prescription home-delivery service nationwide, applying downward pressure on Hims shares, which fell by double-digit percentages on the day. Analysts say the pullback creates a de-risked entry point given Hims’ recent double-digit subscription growth.
1. Competitive Pressure from Amazon Pharmacy
Amazon Pharmacy has rolled out prescription home delivery across all 50 states, intensifying competition in telehealth pharmacy fulfillment. This strategic expansion leverages Amazon’s logistics network to offer faster delivery times and broader coverage, pressuring Hims’ core prescription business.
2. Analyst Perspective on Hims Selloff
Following the announcement, Hims shares dropped by double-digit percentages as investors weighed increased competition. Several analysts characterize the pullback as a de-risked entry point, citing Hims’ continued double-digit subscription growth and path to improved margins.